NCT07133516 A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
| NCT ID | NCT07133516 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Hospital of China Medical University |
| Condition | Artificial Intelligence (AI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2025-07-22 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,600 participants in total. It began in 2025-07-22 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to collaborate with multiple medical institutions to verify the accuracy, stability, and clinical application value of AI algorithms in echocardiographic quantitative measurement through multi-center clinical research. Specific objectives include: 1. Compare the automatic measurement results of AI with the manual measurement data from physicians of different levels, and analyze the measurement deviation and consistency of AI in key parameters such as intracardiac diameter, volume, and function. 2. Investigate whether AI-assisted measurement can significantly reduce echocardiogram analysis time and optimize clinical workflows. Through multi-center data validation, establish a standardized reference system for AI ultrasound measurement, promote the promotion and application of AI technology in medical institutions at all levels, and reduce diagnostic differences between different hospitals and physicians. 3. Exploring the application of AI in special cases: Assessing the measurement stability of AI algorithms in complex cases (such as cardiomyopathy, valvular disease, coronary heart disease, etc.), and optimizing AI models to meet broader clinical needs.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥18 - 80 years; 2. Types of diseases (8 in total, 200 cases each): 1. Normal heart 2. Coronary heart disease (with segmental thinning and abnormal movement) 3. Valve disease (valve stenosis or reflux) 4. Hypertensive heart disease 5. Atrial fibrillation 6. Heart failure 7. Dilated cardiomyopathy 8. Hypertrophic cardiomyopathy Exclusion Criteria: 1. Patients with congenital heart disease 2. Patients with poor image quality
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07133516 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Artificial Intelligence (AI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07133516 currently recruiting?
Yes, NCT07133516 is actively recruiting participants. Contact the research team at cmu1h_mcy@126.com for enrollment information.
Where is the NCT07133516 trial being conducted?
This trial is being conducted at Huainan, China, Fuzhou, China, Meizhou, China, Shantou, China and 11 additional locations.
Who is sponsoring the NCT07133516 clinical trial?
NCT07133516 is sponsored by First Hospital of China Medical University. The trial plans to enroll 1,600 participants.